WP 038
Alternative Names: WP-038Latest Information Update: 28 Aug 2023
At a glance
- Originator Welton Pharma
- Class Antineoplastics; Camptothecins; Indolizines; Pyrans; Quinolines; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Colorectal cancer; Gastrointestinal cancer
Most Recent Events
- 20 Jun 2023 Welton Pharma in-licenses excipient polymer technology, Apisolex™ excipient from Lubrizol Corporation
- 20 Jun 2023 Preclinical trials in Colorectal cancer in USA (Parenteral, Injection), prior to June 2023
- 20 Jun 2023 Preclinical trials in Gastrointestinal cancer in USA (Parenteral, Injection), prior to June 2023